Although the definition of sepsis lacks specificity, and hence is an illness that is commonly underdiagnosed or misdiagnosed, there is little doubt that it affects about 750,000 persons yearly in the US, and kills 25-36% of them. Furthermore, in spite of aggressive therapy, the mortality has not been diminishing. Our interest in sepsis is an outgrowth of laboratory studies of the calcitonin family of hormones, including procalcitonin (ProCT) and its component peptides. This study has spanned approximately three decades. The goal of this manuscript is to describe several recent findings which suggest that the immunoneutralization of ProCT may prove to be a fruitful therapy for sepsis and its allied disorders.
INTRODUCTION
Although the definition of sepsis lacks specificity, and hence is an illness that is commonly underdiagnosed or misdiagnosed, there is little doubt that it affects about 750,000 persons yearly in the US, and kills 25-36% of them. Furthermore, in spite of aggressive therapy, the mortality has not been diminishing. Our interest in sepsis is an outgrowth of laboratory studies of the calcitonin family of hormones, including procalcitonin (ProCT) and its component peptides. This study has spanned approximately three decades. The goal of this manuscript is to describe several recent findings which suggest that the immunoneutralization of ProCT may prove to be a fruitful therapy for sepsis and its allied disorders.
PROCALCITONIN AND ITS COMPONENT CALCITONIN PRECURSORS

Mature calcitonin
Approximately 40 years ago, a 32 amino-acid carboxyterminus-amidated peptide, calcitonin (CT), was found in the thyroid, 1 and then demonstrated to be produced by sparsely distributed neuro-endocrine cells (C cells) located within the thyroid epithelium. Subsequently, CT was also found within pulmonary neuro-endocrine cells (PNE cells) that were interspersed among the epithelial cells of the bronchial tree. 2 Furthermore, small concentrations of immunoreactive CT were localized to other normal tissues of the body. 3 Because mature CT can induce hypocalcemia in experimental animals as calcium infusion stimulates the release of the peptide and because CT provokes a quiescence of bone osteoclasts that thereby restrains the egress of calcium into the blood, it has been assumed to play an important role in calcium metabolism. Nevertheless, in spite of numerous studies, the precise function(s) of the mature CT hormone in human physiology remain enigmatic, other than perhaps the conservation of body calcium during growth, pregnancy, and lactation, and as a buffer against sudden pathological hypercalcemia. 4 Moreover, there is no known human illness which can be attributed to an excess or deficit of mature CT.
ProCT and its component CTpr as markers of sepsis
As is the case for most peptide hormones, CT is biosynthesized from a considerably larger 116 amino acid prohormone, ProCT. ProCT is composed of a centrally placed 33 amino acid immature CT that is glycine-terminated, a 57 amino acid amino-terminus (NProCT), and a 21 amino acid calcitonin carboxy peptide I (CCP-I) at the carboxyl terminus ( Fig. 1) . Lesser amounts of a very similar CCP-II are found, mostly in neurological tissues. Normal serum contains free, discrete peptide components in the following decreasing rank order: NProCT, CCP-I, mature CT, ProCT, and a conjoined CT:CCP-I peptide. 5 In sepsis, severe infections, and systemic inflammation, all of these peptides are increased markedly, although to a variable degree, and sometimes attain levels up to tens of thousands-fold normal levels. Possibly because of incomplete post-translational processing and rapid degradation, levels of mature CT either do not increase or are only modestly elevated. ProCT and the ProCT-derived peptides that are commonly increased in sepsis are collectively termed calcitonin precursors (CTpr); they are markers for this illness and its related conditions. Multiple clinical studies have demonstrated the diagnostic utility of serum CTpr levels in sepsis and their considerable utility in reflecting the severity of this condition and in following the course of patients (Fig. 2) . Furthermore, whether or not bacterial infection can be documented, high levels are encountered in sepsis-like conditions such as pancreatitis, severe burns, heat stroke, chemical pneumonitis, extensive surgery, or severe acute trauma. 6 In several of these conditions, translocation of whole bacteria or endogenously-derived bacterial products (e.g. endotoxin) across the intestinal wall has been demonstrated. Because of the comparative reliability of serum CTpr as a marker of sepsis and sepsis-related conditions, some investigators have speculated that increased levels should be considered a part of the definition of these syndromes. 7 
Ubiquitous secretion of CTpr in sepsis
Reverse transcriptase polymerase chain reaction studies performed in septic animals have revealed elevated levels of CT mRNA in all tissues studied (e.g. brain, liver, lung, fat, skin, testes, etc.). Moreover, in situ hybridization studies have demonstrated that this marked up-regulation of expression involves multiple cell types within these tissues and organs. 8 It appears that this greatly increased gene transcription is mediated by stimulusspecific, sepsis-responsive elements in the gene promotor. 9 In sepsis, this remarkable increase of expression is more universal and specific than is the up-regulation of the classic sepsis-associated cytokines, TNF-a and IL-6; conceptually, the entire body becomes a CTpr-secreting endocrine gland. The word 'hormokine' was coined to signify this cytokine-like host-response in sepsis by peptides of an otherwise classical endocrine family. The mean serum concentration of these peptides in normal adults are indicated. 5 Note that the NProCT and the CCP-I peptides are normally present in higher concentrations than is the mature CT peptide. In sepsis, severe inflammation, and systemic infection, these peptides are greatly increased, although to a varying degree from patient to patient. The mature CT peptide either does not increase or is augmented only minimally. 
The calcitonin gene family of peptides
ProCT and its components are part of a larger family of structurally related entities -the calcitonin gene family of peptides. 4 These originate from the CALC-I gene that gives rise to ProCT and CTpr as well as to the calcitonin gene-related peptide-I (CGRP-I), the CALC-II gene that gives rise to CGRP-II, the CALC-IV gene that gives rise to amylin, and the CALC-V gene that gives rise to adrenomedullin. In sepsis, in addition to CALC-I, the CALC-V gene is also ubiquitously up-regulated;
9,10 as a result, serum values of CGRP and adrenomedullin are both increased, though attaining levels which are markedly less than those of CTpr. The possible significance of the increased levels of serum CGRP and adrenomedullin in sepsis will be discussed below.
DEMONSTRATION OF THE TOXICITY OF ProCT
AND THE THERAPEUTIC EFFICACY OF
IMMUNONEUTRALIZATION
Hamster studies
A model for sepsis in hamsters was achieved by the intraperitoneal placement of agar pellets containing premeasured quantities of Escherichia coli. 11, 12 The 72-h mortality, as well as the levels of serum CTpr, were observed to correlate positively with the number of bacteria administered. The dose was then adjusted to achieve a mortality of approximately 50%. Purified human ProCT, which had been found to be non-toxic in normal hamsters, was injected intravenously into these septic hamsters at the time of implantation of the pellets, resulting in a mortality close to 100% (septic controls, n = 16; sepsis plus ProCT, n = 16; P < 0.03 at 72 h). 13 For comparative purposes, when septic animals were administered mature CT, there was no increase in mortality.
In view of this demonstrable toxicity of ProCT in the presence of sepsis, a therapeutic immunoneutralization was evaluated, utilizing an antiserum reactive to the mid-region of the CT molecule. The result was an appreciable, statistically significant diminution of the 72-h mortality of septic hamsters as compared with untreated septic controls (P < 0.01 and P < 0.045 in two separate experiments involving 64 animals). 13 
Porcine studies
In view of the favorable outcome achieved through immunoneutralization in the hamster model of sepsis, a larger (closer to the human) animal, in which physiological and metabolic parameters could be monitored continuously, was chosen for study. Accordingly, a model for an extremely virulent and rapidly fatal polymicrobial sepsis was developed in the pig.
14 Following anesthesia, intubation, and placement of invasive monitoring devices, sepsis was initiated by spillage of measured quantities of cecal content mixed with a known amount of exogenous E. coli into the peritoneum. Unsterilized cecal content and a strain of E. coli (O18:KI:H7, Walter Reed Army Institute of Research) were utilized. Bacteria were grown in quantity, suspended in phosphate buffered saline (PBS) and glutaraldehyde, and pipetted in 250 ml aliquots into 1 ml freezer vials for storage at -70°C. On the day of the experiment, 2 vials of E. coli were inoculated into 200 ml of Luria Bertani broth (Difco laboratories, Detroit, MI, USA) and grown at 37°C to logarithmic phase (h) in a shaking water bath (SS40-D, Grant Instruments, Barrington, Cambridge, UK). Bacteria were centrifuged (Marathon 21K, Fisher Scientific, Pittsburgh, PA, USA) at 3500 rpm for 30 min to obtain concentrated pellets. They were resuspended in 40 ml of PBS to achieve a concentration of 5 x 10 9 colony forming units/ml (CFU/ml) for a total of 2 x 10 11 CFU. The optical density (OD) of the suspension was measured at 600 nm on a Stasar III spectrophotometer (Gilford Instruments, Oberlin, OH, USA) and quantified by interpolation on a previously constructed curve of OD plotted against CFUs. Following this instillation, nearly all untreated pigs die within 9 h. A predetermined dose of purified non-ProCT-reactive IgG (control) or IgG developed against the amino-terminus portion of porcine ProCT was infused intravenously for 1 h, commencing at the time of induction of the peritonitis. Relative to control animals, the administration of the ProCT-reactive IgG resulted in either a statistically significant improvement or in a beneficial trend in most parameters measured, including urine output, core temperature, arterial pressure, heart rate, cardiac index, stroke index, blood urea nitrogen, creatinine, pH, and arterial lactate. At 15 h after the induction of peritonitis (the predetermined time of euthanasia), only pigs that had been treated with the ProCT-reactive IgG survived. 14 
Late versus early immunoneutralization
Subsequent to the observation of a beneficial effect of ProCT immunoneutralization on the course of sepsis, the effects of a similar therapy that was delayed until the animals were nearly moribund were investigated. A study of untreated animals revealed that nearly all parameters were severely deranged by the fourth hour (Fig.  3) . Consequently, a study was undertaken in which the administration of ProCT-reactive IgG was delayed until this fourth hour. 15 As with early immunoneutralization, late therapy was also successful. Again, at the time of euthanasia the only surviving animals were those who had been treated; all control animals had expired (Fig. 4) . When comparing the late immunoneutralization with early immunoneutralization, there were no statistical differences between the physiological or metabolic parameters or of survival (Table I ). These findings demonstrate a beneficial effect of such therapy, even if the sepsis is recognized late in the course of the disease, at a time when the clinical condition has drastically deteriorated. The studies were performed using polyclonal antibodies; further studies are in preparation utilizing monoclonal antibodies.
THE DYNAMICS AND DURATION OF CTpr SECRETION
Studies in both animals and humans have demonstrated that TNF-a is a strong stimulus to the secretion of CTpr, 12 although it has not been determined whether this cytokine is an obligate proximate excitant. Another known stimulus of CTpr secretion is endotoxin. Investigations in human volunteers have shown that administration of this molecule initially led to an increase of serum levels of TNF-a and IL-6, which was shortly followed by an increase of CTpr. 16 Further exploration of the dynamics of CTpr secretion revealed that when humans were administered endotoxin, serum CTpr levels reached a maximum at 24 h. Remarkably, although progressively decreasing, CTpr levels remained above normal for at least 1 week. 17 In two of these volunteers, values did not return to normal until 2 weeks. In contrast, other studies have shown that the identical dose of endotoxin produces only a transient rise of TNFa that normalizes by 24 h, and similar short-lived increases of several other cytokines (Fig. 5) . Because the elevation of serum CTpr levels persists for a duration considerably longer than the malaise experienced by these volunteers, one can conclude that CTpr require the presence of other factors to induce or perpetuate a septic state.
POSSIBLE CAUSES FOR THE TOXICITY OF ProCT
In humans and in experimental animals, serum CTpr levels correlate positively with the clinical diagnosis of sepsis, its severity, and its prognosis. Furthermore, ProCT administration to septic animals has been found to be toxic, and the therapeutic immunoneutralization of ProCT by IgG reactive to either its CT mid-portion or its amino-terminus portion is markedly beneficial in such animals. Interestingly, preliminary investigations indicated that ProCT administration was not harmful to healthy hamsters, although physiological parameters were not measured. In this regard, there are species specificities of ProCT that may be physiologically relevant; therefore, other animal species should be studied.
In addition, epitope mapping should be employed to study further the precise functional characteristics of these differences. In sepsis, how might this prohormone or components thereof be toxic? Experimental evidence demonstrates or suggests several actions that may perhaps be deleterious in sepsis.
Influence on migration of the monocyte
In studies of CD14 monocytes from normal volunteers, both human ProCT and mature CT provoked an eleva-
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Early immunoneutralization tion of cAMP. 18 Alone, when added to these monocytes in a blind-well chemotaxis chamber, ProCT and CT elicited a dose-dependent migration. However, ProCT inhibited the chemotaxis towards formyl-Met-Leu-Phe, a known chemo-attractant. This reported ProCT stimulation of migration, contrasted with its nullification of the effects of chemo-attractants, seems paradoxical and requires further investigation. The monocyte is a prime initial source of pro-inflammatory cytokines in sepsis; further studies are needed to clarify any possible effects of ProCT on the immune function of this cell that might be deleterious to the host.
Mitogenic action on osteoblast cells
The monocyte is considered to be a precursor of the osteoblast. In this regard, an in vitro study demonstrated a mitogenic action of NProCT on human osteoblast cells; 19 DNA synthesis was increased and, under some circumstances, cAMP levels from rat osteoblasts were augmented. However, other studies are contradictory; therefore, the relevance of these findings to sepsis is unknown.
Cytokine synthesis by monocytes
When monocytes of normal human volunteers were incubated with human ProCT, there was an increased secretion from these cells of TNF-a, IL-1b, and IL-8. 20 Perhaps this is indicative of a positive feedback system by which inflammation results in a yet further increase of ProCT within local, compartmentalized pools of the body.
Increased levels of inducible nitric oxide
In cultured vascular smooth muscle cells of the rat, preincubation with lipopolysaccharide, followed in 3 h by the addition of TNF-a and interferon-g (INF-g) resulted in induction of nitric oxide synthase (iNOS) gene expression. Following a further incubation, the addition of ProCT to these latter two cytokines augmented this response. However, when ProCT alone was utilized, no response occurred. Thus, these findings suggest that, although ineffective as an initiator of inflammation, ProCT acts as a modulator of the inflammatory cascade, thus intensifying the septic host response. 21 
Induction of intracellular calcium increase
An increased intracellular ionized calcium level has been implicated as being a critical factor in the pathophysiology of sepsis by inducing cell injury. 22 Furthermore, attempting to normalize the well-known occurrence of hypocalcemia in sepsis by infusing calcium is hazardous, probably because this further increases intracellular Ca
2+
. Mature CT is a well-known hypocalcemic agent when administered acutely, and the peptide is known to increase intracellular Ca 2+ concentrations. In sepsis, mature CT is not appreciably increased, although ProCT and other CTpr are markedly elevated. Experimentally, it is not known whether CTpr decreases serum calcium. However, serum calcium in septic subjects does correlate inversely with serum CTpr levels, 23 and a similar inverse correlation occurs following endotoxin administration to human volunteers. 16 372 Becker, Nylén, Snider, Müller, White 6 . In this experiment, ProCT and several of its derived peptides were exposed to neutral endopeptidase for 24 h at 37°C. Note the extreme resistance of intact ProCT to degradation and the relatively higher resistance of NProCT as compared to the other peptides.
